BACKGROUND: Patients with malignant biliary obstruction are commonly living longer than previously due to improved oncologic therapies, often exceeding expected times of self-expanding metal stent patency. AIMS: The purpose of this study was to assess the long-term risk and impact of cholangitis in these patients. METHODS: Retrospective review of electronic medical records at an academic medical center. RESULTS: One hundred and one patients had a self-expanding metal stent placed for malignant biliary obstruction. The median survival after SEMS was 214 days. Of these patients, 22 % developed at least one episode of cholangitis requiring inpatient admission, 20 % (9/45) of patients were hospitalized for cholangitis at 6 months, 40 % (8/20) at 1 year, and 75 % (3/4) at 2 years. All of the (8/8) patients receiving chemotherapy prior to hospitalization for cholangitis experienced delays in subsequent chemotherapy. Follow-up of 36 episodes of cholangitis revealed a 14 % 30-day mortality. CONCLUSIONS: Cholangitis develops commonly in long-term survivors with self-expanding metal stents for malignant biliary obstruction, and is associated with delays in chemotherapy and a 14 % 30-day mortality.
BACKGROUND:Patients with malignant biliary obstruction are commonly living longer than previously due to improved oncologic therapies, often exceeding expected times of self-expanding metal stent patency. AIMS: The purpose of this study was to assess the long-term risk and impact of cholangitis in these patients. METHODS: Retrospective review of electronic medical records at an academic medical center. RESULTS: One hundred and one patients had a self-expanding metal stent placed for malignant biliary obstruction. The median survival after SEMS was 214 days. Of these patients, 22 % developed at least one episode of cholangitis requiring inpatient admission, 20 % (9/45) of patients were hospitalized for cholangitis at 6 months, 40 % (8/20) at 1 year, and 75 % (3/4) at 2 years. All of the (8/8) patients receiving chemotherapy prior to hospitalization for cholangitis experienced delays in subsequent chemotherapy. Follow-up of 36 episodes of cholangitis revealed a 14 % 30-day mortality. CONCLUSIONS:Cholangitis develops commonly in long-term survivors with self-expanding metal stents for malignant biliary obstruction, and is associated with delays in chemotherapy and a 14 % 30-day mortality.
Authors: Jennifer J Telford; David L Carr-Locke; Todd H Baron; John M Poneros; Brenna C Bounds; Peter B Kelsey; Robert H Schapiro; Christopher S Huang; David R Lichtenstein; Brian C Jacobson; John R Saltzman; Christopher C Thompson; David G Forcione; Christopher J Gostout; William R Brugge Journal: Gastrointest Endosc Date: 2010-11 Impact factor: 9.427
Authors: Eric Kullman; Farshad Frozanpor; Claes Söderlund; Stefan Linder; Per Sandström; Anna Lindhoff-Larsson; Ervin Toth; Gert Lindell; Eduard Jonas; Jacob Freedman; Martin Ljungman; Claes Rudberg; Bo Ohlin; Rebecka Zacharias; Carl-Eric Leijonmarck; Kalev Teder; Anders Ringman; Gunnar Persson; Mehmet Gözen; Olle Eriksson Journal: Gastrointest Endosc Date: 2010-11 Impact factor: 9.427
Authors: Do Hyun Park; Myung-Hwan Kim; Jung Sik Choi; Sang Soo Lee; Dong Wan Seo; Ji Hye Kim; Jimin Han; Jong Cheol Kim; Eun Kwang Choi; Sung Koo Lee Journal: Clin Gastroenterol Hepatol Date: 2006-05-22 Impact factor: 11.382
Authors: A Ferlitsch; C Oesterreicher; J M Dumonceau; J Deviere; T Leban; P Born; T Rösch; W Suter; J Binek; C Meyenberger; M Müllner; B Schneider; R Schöfl Journal: Endoscopy Date: 2001-08 Impact factor: 10.093
Authors: Joshua Tierney; Neal Bhutiani; Bryce Stamp; John S Richey; Michael H Bahr; Gary C Vitale Journal: Surg Endosc Date: 2017-07-21 Impact factor: 4.584